Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ameluz Duration for Acral Actinic Keratoses
NCT03963102Phase 4Terminated
- Sponsor
- Royal Cornwall Hospitals NHS Trust
- Start
- Oct 2019
- Primary completion
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of aminolevulinic acid 10% gel in actinic keratosis (AK), sponsored by Royal Cornwall Hospitals NHS Trust. Started Oct 2019; status: terminated.
02
Drugs
aminolevulinic acid 10% gel
03
Conditions
actinic keratosis (AK)
Beyond the preview
Go deeper on NCT03963102.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03963102.